Infant lung function after inhaled nitric oxide therapy for persistent pulmonary hypertension of the newborn

Pediatric Pulmonology

Volumn 28, Issue 1, 1999, Pages 24-30

  Dobyns, Emily L ^a,b   Griebel, Jeffery ^a,b   Kinsella, John P ^a,b   Abman, Steven H ^a,b   Accurso, Frank J ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL   (United States)

Author keywords

High frequency oscillatory ventilation; Nitric oxide; Persistent pulmonary hypertension of the newborn; Pulmonary function tests

Indexed keywords

NITRIC OXIDE;

ARTICLE; BREATHING MECHANICS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FUNCTIONAL RESIDUAL CAPACITY; HIGH FREQUENCY VENTILATION; HOSPITAL DISCHARGE; HUMAN; INFANT; INHALATIONAL DRUG ADMINISTRATION; INTERMITTENT MANDATORY VENTILATION; INTERSTITIAL LUNG DISEASE; LUNG FUNCTION; MALE; NEWBORN; NEWBORN INTENSIVE CARE; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

ADMINISTRATION, INHALATION; ANALYSIS OF VARIANCE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HIGH-FREQUENCY VENTILATION; HUMANS; HYPERTENSION, PULMONARY; INFANT, NEWBORN; LUNG VOLUME MEASUREMENTS; MALE; MULTIVARIATE ANALYSIS; NITRIC OXIDE; PROSPECTIVE STUDIES; REFERENCE VALUES; RESPIRATORY FUNCTION TESTS; RESPIRATORY MECHANICS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0033048739     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(199907)28:1<24::AID-PPUL5>3.0.CO;2-M     Document Type: Article

References (24)

1. Goetzman BW, Riemenschneider TA. Persistence of the fetal circulation. Pediatr Rev 1980;2:37-40.
2. Fox WW, Duara S. Persistent pulmonary hypertension in the neonate: diagnosis and management. J Pediatr 1983;103:505-514.
3. Wung JT, James LS, Kilchevsky E, James E. Management of infants with severe respiratory failure and persistence of the fetal circulation without hyperventilation. Pediatrics 1985;76:488-494.
4. Kinsella JP, Neish SR, Shaffer E, Abman SH. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340:819-820.
5. Roberts JD Jr, Polaner DM, Lang P. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992;340: 818-819.
6. Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997;336:597-604.
7. Roberts JD Jr, Fineman JR, Morin FC III, Shaul PW, Rimar S, Schreiber ME, Polin RA, Zwass MS, Zayek MM, Gross I, Heymann MA, Zapol WM. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Engl J Med 1997;336:605-610.
8. Kooy NW, Royall JA, Ye YZ, Kelly DR, Beckman JS. Evidence for in vivo peroxynitrite production in acute lung injury. Am J Respir Crit Care Med 1995;151:1250-1254.
9. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite oxidation of sulfhydryls. J Biol Chem 1991;266:4244-4250.
10. Hallman M, Waffarn F, Bry K, Turbow R, Kleinman MT, Mautz WJ, Rasmussen RE, Phalla DK, Phalen RF. Surfactant dysfunction after inhalation of nitric oxide. J Appl Physiol 1996;80:2026-2034.
11. Kavanagh BP, Mouchawar A, Goldsmith J, Pearl RG. Effects of inhaled NO and inhibition of endogenous NO synthesis in oxidant-induced acute lung injury. J Appl Physiol 1994;76:1324-1329.
12. Ehrlich R, Henry MC. Chronic toxicity of nitrogen dioxide. Arch Environ Health 1968;17:860-865.
13. Greenspan JS, Antunes MJ, Holt WJ, McElwee D, Cullen JA, Spitzer AR. Pulmonary sequelae in infants treated with extracorporeal membrane oxygenation. Pediatr Pulmonol 1997;23:31-38.
14. Rosenberg AA, Kennaugh JM, Moreland SG, Fashaw LM, Hale KA, Torielli FM, Abman SH, Kinsella JP. Longitudinal follow-up of a cohort of newborns treated with inhaled nitric oxide for persistent pulmonary hypertension. J Pediatr 1997;131:70-75.
15. Kinsella JP, Truog WF, Walsh WF, Goldberg RN, Bancalari E, Clark RH, Mayock DE, Redding GJ, de Lemos RA, Sardesci S, McCumin DC. Randomized, multicenter trial of inhaled nitric oxide and high frequency oscillatory ventilation in severe persistent pulmonary hypertension of the newborn (PPHN). J Pediatr 1997;131:55-62.
16. Hanrahan JP, Tager IB, Castile RG, Segal MR, Weiss ST, Speizer FE. Pulmonary function measures in healthy infants: variability and size correction. Am Rev Respir Dis 1990;141:1127-1135.
17. Yang LL, Waffarn F, Lerner M, Fujikawa S, Adintori L. Two-year follow-up of infants with severe persistent pulmonary hypertension treated with inhaled nitric oxide. Pediatr Res 1996;39:285.
18. Riou Y, Storme L, Klosowski S, Cneude F, Jaillard S, Devisme L, Codaccioni X, Matran R, Bobin H, Lequien P. Does inhaled nitric oxide modify lung diffusing capacity and mechanics in experimental hyaline membrane disease (HMD)? Pediatr Res 1996;39: 348.
19. Gerhardt T, Hehre D, Feller R, Reifenberg L, Bancalari E. Serial determination of pulmonary function in infants with chronic lung disease. J Pediatr 1987;110:448-456.
20. Greenspan JS, Abbasi S, Bhutani VK. Sequential changes in pulmonary mechanics in the very low birth weight (1000 grams) infant. J Pediatr 1988;113:732-737.
21. Eissa NT, Ranieri VM, Corbeil D, Chasse M, Bobatto FM, Braidy J, Milic-Emili J. Analysis of behavior of the respiratory system in ARDS patients: effects of flow, volume, and time. J Appl Physiol 1991;70:2719-2729.
22. Tantucci C, Corbeil C, Chasse M, Robatto FM, Nava S, Braidy J, Matar N, Milic-Emili J. Flow and volume dependence of respiratory system flow resistance in patients with adult respiratory distress syndrome. Am Rev Respir Dis 1992;145:355-360.
23. Fanconi S, Kraemer R, Weber J, Tschaeppeler H, Pfenninger J. Long-term sequelae in children surviving adult respiratory distress syndrome. J Pediatr 1985;106:218-222.
24. Newth CJL, Stretton M, Deakers TW, Hammer J. Assessment of pulmonary function in the early phase of ARDS in pediatric patients. Pediatr Pulmonol 1997;23:169-175.